Hjem › Diffust stort B-cellelymfom › Missouri › St. Louis
Kliniske studier for Diffust stort B-cellelymfom i St. Louis, MO
8 studier for Diffust stort B-cellelymfom søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruttererFase 2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruttererFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- og 2 flere
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · 15 mi unna
- Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · 16 mi unna
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RekruttererFase 2
- Cancer Care Specialists of Central Illinois, Swansea · 13 mi unna
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
RekruttererFase 2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Washington University, St. Louis, St Louis
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruttererFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- og 2 flere
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
RekruttererFase 2
- Siteman Cancer Center at Washington University, St Louis
Diffust stort B-cellelymfom-studier i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Prostatakreft46 studier
- Kreft (alle typer)46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.